Italy’s prevention market expands beyond the clinic

Robin Health’s new mapping shows how prevention in Italy is spreading into digital tools, at-home testing, wearables and workplace benefits. The shift could make care more continuous, but access remains uneven as private and employer-linked services grow faster than public coverage.

Why it matters: - Italy’s prevention market is moving from one-off check-ups to ongoing monitoring, with new services that can track risk, guide diagnosis and extend care beyond hospitals. - The shift could make prevention more convenient and earlier interventions more likely. - Access is still uneven. Many of the mapped services are private or tied to employers and insurers. - That matters in a country where millions already delay or skip needed care because of waiting lists and cost.

What happened: - Robin Health compiled an initial map of organisations operating in Italy in prevention, early diagnosis and health management. - The mapping covers digital platforms, at-home diagnostics, wearable devices and corporate welfare programmes. - The organisations mapped include Robin Health, Qura, Empatica, Medicilio, Lab Evo, Carol, Health Italia, Health Triage and SynDiag. - The review identifies four shifts in Italy’s prevention ecosystem: from occasional check-ups to continuous monitoring; from clinics to at-home services; from the individual to the workplace; and from general prevention to more specialised pathways.

The details: - The mapped ecosystem spans general check-ups, cancer prevention, metabolic health and at-home diagnostics. - Technology is being used to support earlier diagnosis, collect data over time and move parts of care outside traditional facilities. - The services are aimed mainly at individuals, but the corporate channel is growing as employers use welfare schemes for continuous prevention programmes. - Robin Health CEO and Co-Founder Giacomo De Lorenzo said prevention needs continuity between medical appointments and everyday life, and that new services should be integrated with healthcare professionals while reaching people currently excluded. - Istat’s 2026 BES Report shows that in 2025, 9.6% of Italy’s population, or more than 5.6 million people, went without at least one medical consultation or diagnostic test despite needing it. - That figure was up from 8.1% in 2017. - The main reasons were waiting lists at 6.5% and service costs at 5.2%. - Between 2023 and 2024, the share of people who paid the full cost of their most recent healthcare service rose from 19.9% to 23.9%.

Between the lines: - The mapping suggests Italy’s prevention market is becoming more modular, with companies packaging diagnostics, monitoring and consultations into services that can be delivered outside the traditional clinic. - The workplace is emerging as a major distribution channel, which could widen access for insured employees while leaving others behind. - The access data points to a structural tension: prevention is becoming more available in theory, but not necessarily more universal in practice.

What’s next: - Robin Health’s mapping is an initial snapshot, not a final inventory. - More companies and models may emerge as digital health, wearables and at-home diagnostics expand. - The key test will be whether these services can connect with clinicians and public pathways, not just private payers. - The bigger question is whether prevention tools can reach people who are currently excluded by cost, waiting times or lack of coverage.

The bottom line: - Italy’s prevention market is moving outside the clinic, but the access gap remains the central challenge.